Pfizer Total Revenue from 2010 to 2026
| PFE Stock | EUR 23.34 0.10 0.43% |
Total Revenue | First Reported 2016-12-31 | Previous Quarter 14.7 B | Current Value 16.7 B | Quarterly Volatility 4.5 B |
Check Pfizer financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pfizer's main balance sheet or income statement drivers, such as Discontinued Operations of 6.6 M, Interest Expense of 3.7 B or Selling General Administrative of 11.2 B, as well as many indicators such as Price To Sales Ratio of 2.16, Dividend Yield of 0.0727 or PTB Ratio of 1.85. Pfizer financial statements analysis is a perfect complement when working with Pfizer Valuation or Volatility modules.
Pfizer | Total Revenue |
The Total Revenue trend for Pfizer Inc offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Pfizer is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Pfizer's Total Revenue Growth Pattern
Below is the plot of the Total Revenue of Pfizer Inc over the last few years. Total revenue comprises all receipts Pfizer Inc generated from the sale of its products or services. It is the total amount of income generated by the sale of goods or services related to the company's primary operations. Pfizer's Total Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pfizer's overall financial position and show how it may be relating to other accounts over time.
| Total Revenue | 10 Years Trend |
|
Total Revenue |
| Timeline |
Pfizer Total Revenue Regression Statistics
| Arithmetic Mean | 58,418,473,529 | |
| Geometric Mean | 56,976,521,392 | |
| Coefficient Of Variation | 25.18 | |
| Mean Deviation | 10,947,318,685 | |
| Median | 52,546,000,000 | |
| Standard Deviation | 14,711,093,275 | |
| Sample Variance | 216416265.3T | |
| Range | 58.4B | |
| R-Value | 0.59 | |
| Mean Square Error | 149785910.6T | |
| R-Squared | 0.35 | |
| Significance | 0.01 | |
| Slope | 1,726,290,074 | |
| Total Sum of Squares | 3462660245.5T |
Pfizer Total Revenue History
About Pfizer Financial Statements
Pfizer stakeholders use historical fundamental indicators, such as Pfizer's Total Revenue, to determine how well the company is positioned to perform in the future. Although Pfizer investors may analyze each financial statement separately, they are all interrelated. For example, changes in Pfizer's assets and liabilities are reflected in the revenues and expenses on Pfizer's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Pfizer Inc. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 73.2 B | 65.6 B |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of Pfizer Correlation against competitors. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.